Literature DB >> 12434001

Role of tumor suppressor p53 domains in selective binding to supercoiled DNA.

Marie Brázdová1, Jan Palecek, Dmitry I Cherny, Sabina Billová, Miroslav Fojta, Petr Pecinka, Borivoj Vojtesek, Thomas M Jovin, Emil Palecek.   

Abstract

We showed previously that bacterially expressed full-length human wild-type p53b(1-393) binds selectively to supercoiled (sc)DNA in sc/linear DNA competition experiments, a process we termed supercoil-selective (SCS) binding. Using p53 deletion mutants and pBluescript scDNA (lacking the p53 recognition sequence) at native superhelix density we demonstrate here that the p53 C-terminal domain (amino acids 347-382) and a p53 oligomeric state are important for SCS binding. Monomeric p53(361-393) protein (lacking the p53 tetramerization domain, amino acids 325-356) did not exhibit SCS binding while both dimeric mutant p53(319- 393)L344A and fusion protein GCN4-p53(347-393) were effective in SCS binding. Supershifting of p53(320-393)-scDNA complexes with monoclonal antibodies revealed that the amino acid region 375-378, constituting the epitope of the Bp53-10.1 antibody, plays a role in binding of the p53(320-393) protein to scDNA. Using electron microscopy we observed p53-scDNA nucleoprotein filaments produced by all the C-terminal proteins that displayed SCS binding in the gel electrophoresis experiments; no filaments formed with the monomeric p53(361- 393) protein. We propose a model according to which two DNA duplexes are compacted into p53-scDNA filaments and discuss a role for filament formation in recombination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434001      PMCID: PMC137164          DOI: 10.1093/nar/gkf616

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.

Authors:  T Yakovleva; A Pramanik; T Kawasaki; K Tan-No; I Gileva; H Lindegren; U Langel; T J Ekstrom; R Rigler; L Terenius; G Bakalkin
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

2.  Scanning force microscopy of the complexes of p53 core domain with supercoiled DNA.

Authors:  S D Jett; D I Cherny; V Subramaniam; T M Jovin
Journal:  J Mol Biol       Date:  2000-06-09       Impact factor: 5.469

3.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

4.  p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core.

Authors:  S B Zotchev; M Protopopova; G Selivanova
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

5.  Electron and scanning force microscopy studies of alterations in supercoiled DNA tertiary structure.

Authors:  D I Cherny; T M Jovin
Journal:  J Mol Biol       Date:  2001-10-19       Impact factor: 5.469

6.  p53 blocks RuvAB promoted branch migration and modulates resolution of Holliday junctions by RuvC.

Authors:  Vidya P Prabhu; Amanda M Simons; Hiroshi Iwasaki; Dahai Gai; Daniel T Simmons; Junghuei Chen
Journal:  J Mol Biol       Date:  2002-03-08       Impact factor: 5.469

Review 7.  Post-translational modifications and activation of p53 by genotoxic stresses.

Authors:  E Appella; C W Anderson
Journal:  Eur J Biochem       Date:  2001-05

8.  Binding of p53 and its core domain to supercoiled DNA.

Authors:  E Palecek; M Brázdová; V Brázda; J Palecek; S Billová; V Subramaniam; T M Jovin
Journal:  Eur J Biochem       Date:  2001-02

9.  Determination of glutathione-S-transferase traces in preparations of p53 C-terminal domain (aa320-393).

Authors:  Marie Brázdová; René Kizek; Ludek Havran; Emil Palecek
Journal:  Bioelectrochemistry       Date:  2002-01       Impact factor: 5.373

10.  Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box B-domain of HMG1 protein to supercoiled DNA.

Authors:  M Stros; J Reich
Journal:  Eur J Biochem       Date:  1998-01-15
View more
  17 in total

1.  Comparison of the protein-protein interfaces in the p53-DNA crystal structures: towards elucidation of the biological interface.

Authors:  Buyong Ma; Yongping Pan; K Gunasekaran; R Babu Venkataraghavan; Arnold J Levine; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

2.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel.

Authors:  Abel González-Pérez; Nuria López-Bigas
Journal:  Am J Hum Genet       Date:  2011-03-31       Impact factor: 11.025

3.  A novel germline mutation of TP53 with breast cancer diagnosed as Li-Fraumeni syndrome.

Authors:  Masaya Kai; Makoto Kubo; Sawako Shikada; Saori Hayashi; Takafumi Morisaki; Mai Yamada; Yuka Takao; Akiko Shimazaki; Yurina Harada; Kazuhisa Kaneshiro; Yusuke Mizuuchi; Koji Shindo; Masafumi Nakamura
Journal:  Surg Case Rep       Date:  2022-10-11

4.  Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.

Authors:  Jana Kasparkova; Miroslav Fojta; Nicholas Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

Review 5.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

6.  Change of the protein p53 electrochemical signal according to its structural form - quick and sensitive distinguishing of native, denatured, and aggregated form of the "guardian of the genome".

Authors:  David Potesil; Radka Mikelova; Vojtech Adam; Rene Kizek; Richard Prusa
Journal:  Protein J       Date:  2006-01       Impact factor: 4.000

Review 7.  Cruciform structures are a common DNA feature important for regulating biological processes.

Authors:  Václav Brázda; Rob C Laister; Eva B Jagelská; Cheryl Arrowsmith
Journal:  BMC Mol Biol       Date:  2011-08-05       Impact factor: 2.946

8.  Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences.

Authors:  Marie Brázdová; Timo Quante; Lars Tögel; Korden Walter; Christine Loscher; Vlastimil Tichý; Lenka Cincárová; Wolfgang Deppert; Genrich V Tolstonog
Journal:  Nucleic Acids Res       Date:  2009-01-12       Impact factor: 16.971

9.  Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Authors:  Marie Brázdová; Lucie Navrátilová; Vlastimil Tichý; Kateřina Němcová; Matej Lexa; Roman Hrstka; Petr Pečinka; Matej Adámik; Borivoj Vojtesek; Emil Paleček; Wolfgang Deppert; Miroslav Fojta
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Functional four-base A/T gap core sequence CATTAG of P53 response elements specifically bound tetrameric P53 differently than two-base A/T gap core sequence CATG bound both dimeric and tetrameric P53.

Authors:  Bi-He Cai; Jang-Yi Chen; Mei-Hua Lu; Li-Tze Chang; Hwang-Chi Lin; Yu-Ming Chang; Chung-Faye Chao
Journal:  Nucleic Acids Res       Date:  2009-02-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.